Breast Cancer Res. 2005;7(1):1-4. Epub 2004 Oct 28.

Deficits in plasma oestradiol measurement in studies and management of breast cancer.

Source

Academic Department of Biochemistry, The Royal Marsden Hospital, London, UK. mitch.dowsett@icr.ac.uk

Abstract

The determination of plasma oestradiol has numerous applications in epidemiology, reproductive medicine and breast cancer management. Commercially available analytical methods, which measure the hormone levels without prior purification, have been successfully developed for measuring oestradiol in premenopausal women. The application of these methodologies to the quantification of the very low levels of oestradiol in postmenopausal women is more problematic in terms of accuracy and interpretation. The importance of using appropriate methodology is discussed and illustrated with data demonstrating the disparity in the results obtained when low levels of oestradiol were quantified using direct and indirect methods.

Comment in

Breast Cancer Res. 2005;7(2):45-7.

PMID:: 15642174; [PubMed - indexed for MEDLINE]
PMCID: PMC1064106

Free PMC Article

Images from this publication.See all images (2) Free text

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Estradiol

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

Pre-operative oestradiol levels - relation to survival in breast cancer. [Eur J Surg Oncol. 2001]
Pre-operative oestradiol levels - relation to survival in breast cancer.
Holmberg L, Nordén T, Lindgren A, Wide L, Degerman M, Adami HO. Eur J Surg Oncol. 2001 Mar; 27(2):152-6.
Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. [J Natl Cancer Inst. 2005]
Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE. J Natl Cancer Inst. 2005 Apr 20; 97(8):595-602.
Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels. [J Steroid Biochem Mol Biol. 2007]
Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels.
Geisler J, Haynes B, Ekse D, Dowsett M, Lønning PE. J Steroid Biochem Mol Biol. 2007 Apr; 104(1-2):27-34. Epub 2007 Mar 9.
Review The relationship between factors affecting endogenous oestradiol levels in postmenopausal women and breast cancer. [J Steroid Biochem Mol Biol. 2006]
Review The relationship between factors affecting endogenous oestradiol levels in postmenopausal women and breast cancer.
Folkerd EJ, Martin LA, Kendall A, Dowsett M. J Steroid Biochem Mol Biol. 2006 Dec; 102(1-5):250-5. Epub 2006 Oct 17.
Review Endogenous hormones and risk of breast cancer in postmenopausal women. [Breast Dis. 2005]
Review Endogenous hormones and risk of breast cancer in postmenopausal women.
Hankinson SE. Breast Dis. 2005-2006; 24:3-15.

See reviews... See all...

Cited by 4 PubMed Central articles

Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women. [J Clin Oncol. 2010]
Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women.
Dunbier AK, Anderson H, Ghazoui Z, Folkerd EJ, A'hern R, Crowder RJ, Hoog J, Smith IE, Osin P, Nerurkar A, et al. J Clin Oncol. 2010 Mar 1; 28(7):1161-7. Epub 2010 Feb 1.
Review Analysis of estrogens in serum and plasma from postmenopausal women: past present, and future. [Steroids. 2010]
Review Analysis of estrogens in serum and plasma from postmenopausal women: past present, and future.
Blair IA. Steroids. 2010 Apr; 75(4-5):297-306. Epub 2010 Jan 28.
Human chorionic gonadotropin (hCG) prevents the transformed phenotypes induced by 17 beta-estradiol in human breast epithelial cells. [Cell Biol Int. 2009]
Human chorionic gonadotropin (hCG) prevents the transformed phenotypes induced by 17 beta-estradiol in human breast epithelial cells.
Kocdor H, Kocdor MA, Russo J, Snider KE, Vanegas JE, Russo IH, Fernandez SV. Cell Biol Int. 2009 Nov; 33(11):1135-43. Epub 2009 Jul 30.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Deficits in plasma oestradiol measurement in studies and management of breast ca...
Deficits in plasma oestradiol measurement in studies and management of breast cancer.
Breast Cancer Res. 2005 ;7(1):1-4. Epub 2004 Oct 28 .

PubMed
Imaging in breast cancer: Magnetic resonance spectroscopy.
Imaging in breast cancer: Magnetic resonance spectroscopy.
Breast Cancer Res. 2005 ;7(4):149-52. Epub 2005 May 12 .

PubMed
Breast cancer endocrine resistance: how growth factor signaling and estrogen rec...
Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response.
Clin Cancer Res. 2003 Jan ;9(1 Pt 2):447S-54S.

PubMed
Hereditary cancer syndromes.
Hereditary cancer syndromes.
Arch Pathol Lab Med. 2001 Jan ;125(1):85-90.

PubMed
Dissemination and growth of cancer cells in metastatic sites.
Dissemination and growth of cancer cells in metastatic sites.
Nat Rev Cancer. 2002 Aug ;2(8):563-72.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Deficits in plasma oestradiol measurement in studies and management of breast cancer.

Source

Abstract

Comment in

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Libraries

Supplemental Content

Related citations

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information